Back to search
FDAFDA · Food and drugs·Recall number D-0934-2023

Norepinephrine 32 mg per 250 mL (128 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-702-01.

Published July 26, 2023 · Recall initiated: July 7, 2023

Summary

FDA records drug Class II recall D-0934-2023, published July 26, 2023 and initiated July 7, 2023. Recalling firm: SterRx, LLC; Status: Terminated; Reported quantity: 2,088 bags; Lot: Lot #: 490100, Exp 27-Jul-23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SterRx, LLC
Distributor
Nationwide in the USA
Lot
Lot #: 490100, Exp 27-Jul-23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine 32 mg per 250 mL (128 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-702-01. recalled?

Yes. FDA published recall D-0934-2023 on July 26, 2023. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter